Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Sebo

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Pathology|January 19, 2006
Analysis of polyomavirus-infected renal transplant recipients' urine specimens: correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysisBenjamin R Kipp, Thomas J Sebo, Matthew D Griffin, et al.
Thyroid : Official Journal of the American Thyroid Association|April 3, 2013
Symptomatic amyloid goiters: report of five casesJennie H Law, Diana S Dean, Berndt Scheithauer, et al.
Clinical Endocrinology|January 6, 2015
Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literatureNaykky Singh Ospina, Thomas J Sebo, Geoffrey B Thompson, et al.
The Journal of Urology|August 21, 2007
Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral refluxJonathan C Routh, Richard A Ashley, Thomas J Sebo, et al.
The Journal of Urology|March 11, 2005
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen eraDavid S DiMarco, Horst Zincke, Thomas J Sebo, et al.
American Journal of Clinical Pathology|February 27, 2004
An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarraysSchuyler O Sanderson, Thomas J Sebo, Linda M Murphy, et al.
Urologic Oncology|February 19, 2004
Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?John F Ward, George Bartsch, Thomas J Sebo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2003
Identifying and quantifying apoptosis: navigating technical pitfallsMegan M Garrity, Lawrence J Burgart, Darren L Riehle, et al.
Human Pathology|August 21, 2007
Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumorsWilliam R Sukov, John C Cheville, Donna J Lager, et al.
Urology|October 11, 2003
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcomeKent G Krejci, Michael L Blute, John C Cheville, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Pathology|January 19, 2006
Analysis of polyomavirus-infected renal transplant recipients' urine specimens: correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysisBenjamin R Kipp, Thomas J Sebo, Matthew D Griffin, et al.
Thyroid : Official Journal of the American Thyroid Association|April 3, 2013
Symptomatic amyloid goiters: report of five casesJennie H Law, Diana S Dean, Berndt Scheithauer, et al.
Clinical Endocrinology|January 6, 2015
Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literatureNaykky Singh Ospina, Thomas J Sebo, Geoffrey B Thompson, et al.
The Journal of Urology|August 21, 2007
Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral refluxJonathan C Routh, Richard A Ashley, Thomas J Sebo, et al.
The Journal of Urology|March 11, 2005
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen eraDavid S DiMarco, Horst Zincke, Thomas J Sebo, et al.
American Journal of Clinical Pathology|February 27, 2004
An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarraysSchuyler O Sanderson, Thomas J Sebo, Linda M Murphy, et al.
Urologic Oncology|February 19, 2004
Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?John F Ward, George Bartsch, Thomas J Sebo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2003
Identifying and quantifying apoptosis: navigating technical pitfallsMegan M Garrity, Lawrence J Burgart, Darren L Riehle, et al.
Human Pathology|August 21, 2007
Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumorsWilliam R Sukov, John C Cheville, Donna J Lager, et al.
Urology|October 11, 2003
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcomeKent G Krejci, Michael L Blute, John C Cheville, et al.
Pageof 13